Related references
Note: Only part of the references are listed.Structural basis of BAK activation in mitochondrial apoptosis initiation
Geetika Singh et al.
NATURE COMMUNICATIONS (2022)
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
Sarah T. Diepstraten et al.
NATURE REVIEWS CANCER (2022)
Evaluating and evolving a screening library in academia: the St Jude approach
Gisele Nishiguchi et al.
DRUG DISCOVERY TODAY (2021)
Venetoclax and navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Vinod A. Pullarkat et al.
CANCER DISCOVERY (2021)
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity
Dongwen Lv et al.
NATURE COMMUNICATIONS (2021)
Pharmacological Targeting of Executioner Proteins: Controlling Life and Death
Justin P. Pogmore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structure of detergent-activated BAK dimers derived from the inert monomer
Richard W. Birkinshaw et al.
MOLECULAR CELL (2021)
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W. Roberts et al.
BLOOD (2021)
High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane
Laura E. Sperl et al.
EMBO JOURNAL (2021)
Dynamic reconfiguration of pro-apoptotic BAK on membranes
Jarrod J. Sandow et al.
EMBO JOURNAL (2021)
Discovery of Small Molecule Bak Activator for Lung Cancer Therapy
Dongkyoo Park et al.
THERANOSTICS (2021)
BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins
Tudor Moldoveanu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2020)
Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target
Sweta Iyer et al.
CELL DEATH & DISEASE (2020)
BAK core dimers bind lipids and can be bridged by them
Angus D. Cowan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Therapeutic development and current uses of BCL-2 inhibition
Andrew W. Roberts
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Pore formation in regulated cell death
Hector Flores-Romero et al.
EMBO JOURNAL (2020)
Bax to the future - A novel, high-yielding approach for purification and expression of full-length Bax protein for structural studies
Artur P. G. Dingeldein et al.
PROTEIN EXPRESSION AND PURIFICATION (2019)
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis
Mark F. van Delft et al.
NATURE CHEMICAL BIOLOGY (2019)
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Rumani Singh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Intrinsic Instability of BOK Enables Membrane Permeabilization in Apoptosis
Janet H. Zheng et al.
CELL REPORTS (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design
Jason M. Brouwer et al.
MOLECULAR CELL (2017)
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Avi Ashkenazi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection
Xin Niu et al.
CELL CHEMICAL BIOLOGY (2017)
Small molecules reveal an alternative mechanism of Bax activation
Hetal Brahmbhatt et al.
BIOCHEMICAL JOURNAL (2016)
Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
Katelyn L. O'Neill et al.
GENES & DEVELOPMENT (2016)
CcpNmr AnalysisAssign: a flexible platform for integrated NMR analysis
Simon P. Skinner et al.
JOURNAL OF BIOMOLECULAR NMR (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies
Sweta Iyer et al.
NATURE COMMUNICATIONS (2016)
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies
Alex R. D. Delbridge et al.
NATURE REVIEWS CANCER (2016)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Discovery of Small Molecules that Inhibit the Disordered Protein, p27Kip1
Luigi I. Iconaru et al.
SCIENTIFIC REPORTS (2015)
Identification of Inhibitors Against BAK Pore Formation using an Improved in vitro Assay System
Seong-Soo Song et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2014)
Organization of the Mitochondrial Apoptotic BAK Pore OLIGOMERIZATION OF THE BAK HOMODIMERS
Sreevidya Aluvila et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Bak Core and Latch Domains Separate during Activation, and Freed Core Domains Form Symmetric Homodimers
Jason M. Brouwer et al.
MOLECULAR CELL (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Many players in BCL-2 family affairs
Tudor Moldoveanu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents
Xuliang Lang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
A new method to customize protein expression vectors for fast, efficient and background free parallel cloning
Judith Scholz et al.
BMC BIOTECHNOLOGY (2013)
Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis
Peter E. Czabotar et al.
CELL (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
BID-induced structural changes in BAK promote apoptosis
Tudor Moldoveanu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Direct activation of full-length proapoptotic BAK
Elizaveta S. Leshchiner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bax dimerizes via a symmetric BH3:groove interface during apoptosis
G. Dewson et al.
CELL DEATH AND DIFFERENTIATION (2012)
Accelerated NMR Spectroscopy by Using Compressed Sensing
Krzysztof Kazimierczuk et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Fabien Llambi et al.
MOLECULAR CELL (2011)
Conformational Changes in BAK, a Pore-forming Proapoptotic Bcl-2 Family Member, upon Membrane Insertion and Direct Evidence for the Existence of BH3-BH3 Contact Interface in BAK Homo-oligomers
Kyoung Joon Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
Bak Activation for Apoptosis Involves Oligomerization of Dimers via Their α6 Helices
Grant Dewson et al.
MOLECULAR CELL (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: Groove interactions
Grant Dewson et al.
MOLECULAR CELL (2008)
Cell-free analysis of tail-anchor protein targeting to membranes
Matthew P. A. Henderson et al.
METHODS (2007)
The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site
Tudor Moldoveanu et al.
MOLECULAR CELL (2006)
Share Paper
